Adapti (ADTI) stock price is $0.01, unchanged on the day, as of Nov 12, 2026. It has a market cap of $80.99K, and is classified in the Cosmetics industry (Consumer Staples sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap80,987.29
P/E-0.01
FCF (Yr)–
ROA (Yr)–
EV to EBIT0.28
Net Income (Yr)–
Enterprise Value-1.58 Mn
Add ratio to table…
About
Adapti, Inc. manages the sales and brand development of a line of health and beauty products sold under the trade name Dermacia. The company also develops and maintains an artificial intelligence platform named Adapti that is designed to match consumer products with social media influencers for optimized marketing outcomes. Although the Dermacia brand has been offered for sale through the company’s website and various online marketplaces, it has historically generated only…
Adapti, Inc. manages the sales and brand development of a line of health and beauty products sold under the trade name Dermacia. The company also develops and maintains an artificial intelligence platform named Adapti that is designed to match consumer products with social media influencers for optimized marketing outcomes. Although the Dermacia brand has been offered for sale through the company’s website and various online marketplaces, it has historically generated only modest annual sales below fifteen thousand dollars. The Adapti software was completed in 2024 after approximately five hundred thousand dollars of development spending and has not yet generated revenue. The firm’s current operations center on the Dermacia product line while it continues to refine its AI technology and evaluates potential acquisitions that could expand its business scope.
Adapti, Inc. derives its revenue primarily from the sale of Dermacia branded cosmetics through its proprietary website and third party online retailers. The company reports that yearly sales of the Dermacia line have consistently remained under fifteen thousand dollars, reflecting limited market penetration and brand recognition. The Adapti artificial intelligence platform has not yet contributed any income to the firm, as it remains in a testing and development phase with only a few internal pilot projects completed. Management anticipates that future revenue could emerge from licensing the Adapti software to external brands or from performance based fees tied to influencer campaigns, but such streams are speculative at present. Until the planned acquisitions of the Ballengee Group and Matchpoint Connections are completed, the company’s financial results will continue to depend almost exclusively on the modest sales of its Dermacia product line.
Adapti, Inc. operates in two distinct but related markets that shape its competitive environment. The Dermacia cosmetics line competes in the crowded health and beauty sector where large established brands and numerous niche players vie for consumer attention through retail channels and digital advertising. The company’s low sales volume and limited brand awareness place it far behind industry leaders that benefit from extensive distribution networks and substantial marketing budgets. The Adapti artificial intelligence platform faces competition from established influencer marketing agencies and emerging technology firms that offer similar data driven matchmaking services. Competitors referenced in the filing include Klutch Sports Group, Distinction Agency, MOGL, and Socially Powerful, which combine athlete representation with creative campaign execution and direct access to large influencer networks. Adapti differentiates itself by emphasizing a proprietary algorithm that creates a data fingerprint for products and influencers, aiming to deliver measurable return on advertising spend through automated recommendations. However, the technology remains unproven at scale and the firm lacks the track record, client base, and resources of its rivals, which currently constrains its ability to capture meaningful market share.
Adapti, Inc. serves individual consumers who purchase Dermacia cosmetics through its website and various online marketplaces, although the firm does not disclose specific purchaser names or demographic details. The Adapti software is intended to serve brands seeking influencer partnerships and social media influencers looking for suitable product endorsements, yet the platform has not secured any external customers to date. Should the contemplated acquisitions proceed, the company expects to expand its customer base to include professional baseball agencies, universities managing name image and likeness rights for athletes, and commercial brands that wish to target sports personalities through targeted influencer campaigns. Until those transactions close, the firm’s revenue relies on the limited retail sales of its Dermacia line to anonymous online shoppers.
Sectors:Consumer Staples·TechnologySector rationaleThe company's only current source of revenue is the sale of Dermacia branded cosmetics to consumers via its website and online marketplaces, which falls under Personal Care Products in Consumer Staples. A secondary sector of Technology is justified because the company has developed a proprietary AI platform for influencer matchmaking, which it intends to license to external brands as a distinct business line.Industries:CosmeticsCosmeticsPrimaryThe company's current revenue is derived almost exclusively from the sale of Dermacia branded cosmetics. These products are sold to individual consumers through the company's website and third-party online retailers.Marketing SoftwareMarketing SoftwareSecondaryThe company has developed an AI platform named Adapti designed to match consumer products with social media influencers for optimized marketing outcomes. This software is intended to be licensed to external brands for influencer campaign management.Classified using BQ-MICSCIK: 0001420924
Peer percentiles
How Adapti ranks
Ranked against the 60 companies in Household and Personal Products·58 metrics · as of Nov 14, 2026
Valuation
12 metrics · Lower multiples rank higher; a negative multiple ranks last